Clinical Trial Update: Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating treatment for pneumonic-type adenocarcinoma and lung adenocarcinoma with bronchioloalveolar features has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma with Bronchioloalveolar Feature
• Pneumonic-type Adenocarcinoma

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Pneumonic-type Adenocarcinoma (P-ADC), Lung Adenocarcinoma With Bronchiolo-alveolar Feature | Phase 2 | Status: COMPLETED